Shared-ownership Microfinance

Last registered on March 29, 2020
View Trial History

Pre-Trial

Trial Information

General Information

Title
Shared-ownership Microfinance
RCT ID
AEARCTR-0003886
Initial registration date
February 14, 2019

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
February 15, 2019, 4:13 PM EST

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
March 29, 2020, 10:25 AM EDT

Last updated is the most recent time when changes to the trial's registration were published.

Locations

Country
Pakistan
Region

Primary Investigator

Name
Muhammad Meki
Affiliation
University of Oxford
Contact Primary Investigator

Other Primary Investigator(s)

PI Name
Simon Quinn
PI Affiliation
University of Oxford
Contact Investigator
PI Name
Kashif Malik
PI Affiliation
Lahore University of Management Sciences
Contact Investigator
PI Name
Faisal Bari
PI Affiliation
Lahore University of Management Sciences
Contact Investigator

Additional Trial Information

Status
On going
Start date
2016-12-20
End date
2020-05-19
Keywords
Finance & Microfinance
Additional Keywords
JEL code(s)
Secondary IDs
Abstract
In this study, we work with one of the fastest-growing microfinance institutions in Pakistan to conduct a field experiment where we offer a relatively large amount of financing to microenterprise owners who have graduated from small-scale borrowing and expressed an interest in financing a fixed asset for their business. We use a shared-ownership contract to finance the purchase of the asset.
External Link(s)

Registration Citation

Citation
Bari, Faisal et al. 2020. "Shared-ownership Microfinance." AEA RCT Registry. March 29. https://doi.org/10.1257/rct.3886-1.1
Former Citation
Bari, Faisal et al. 2020. "Shared-ownership Microfinance." AEA RCT Registry. March 29. https://www.socialscienceregistry.org/trials/3886/history/65118
Sponsors & Partners
Experimental Details

Interventions

Intervention(s)
We have designed two financial contracts to help finance the purchase of the assets, which differ in terms of the repayment flexibility permitted. They are discussed in detail in the pre-analysis plan document.
Intervention Start Date
2016-12-20
Intervention End Date
2020-05-19

Primary Outcomes

Primary Outcomes (end points)
Our key hypothesis is that our treatments affect the performance of respondents’ businesses.
Primary Outcomes (explanation)
Our primary outcome family, therefore, is the set of variables earlier labelled as ‘BUSINESS PERFORMANCE’, and described in detail in the pre-analysis plan document.

Secondary Outcomes

Secondary Outcomes (end points)
We hypothesise that the treatments do this by increasing the stock of respondents' business assets.
Secondary Outcomes (explanation)
Our primary family of mechanisms, therefore, is the set of variables earlier labelled as BUSINESS ASSETS, and described in detail in the pre-analysis plan document.

Experimental Design

Experimental Design
We use a randomised controlled trial design, in which respondents are assigned either to a control group or to one of two treatment groups. This process is described in more detail in the pre-analysis plan document.
Experimental Design Details
We use a randomised controlled trial design, in which respondents are assigned either to a control group or to one of two treatment groups. Individuals in treatment 1 are assignment to a fixed-repayment contract, and those in treatment 2 are offered a flexible-repayment contract to finance the purchase of their desired assets. Randomisation was stratified on microenterprise type, performance and gender, using matched sextuplets. This process is described in more detail in the pre-analysis plan document.
Randomization Method
Done by a computer.
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
757 individuals
Sample size: planned number of observations
757 individuals
Sample size (or number of clusters) by treatment arms
254 individuals assigned to control, 257 assigned to treatment 1, and 246 assigned to treatment 2.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials
IRB

Institutional Review Boards (IRBs)

IRB Name
Department Research Ethics Committee, Department of Economics, University of Oxford
IRB Approval Date
2016-07-12
IRB Approval Number
Ref No: R37860/RE002
Analysis Plan

Analysis Plan Documents

Shared-ownership Microfinance analysis plan

MD5: 2e198e0562600b66d34b8577bca51f1a

SHA1: fea5ec250b9fdebaa00329da54dc7dc0144e8cf7

Uploaded At: February 14, 2019

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials